drugset / Trial / NCT00059878

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

NCT00059878 ↗

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Antifungals such as voriconazole may be effective in controlling fungal infections. Combining voriconazole with interferon gamma may be more effective than voriconazole alone in treating fungal infections. PURPOSE: Randomized phase II trial to compare the effectiveness of voriconazole with or without interferon gamma in treating patients who have aspergillosis or other fungal infections.

Timeline

Start
2003-08
Primary completion
—
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule — Intravenous
Subject recombinant interferon gamma Protein / enzyme biologic — Subcutaneous